Abstract
Selective inhibitors of TNF-alpha Converting Enzyme (TACE) based on (1R,2S)-cyclopentyl, (3S,4S)-pyrrolidinyl, and (3R,4S)-tetrahydrofuranyl beta-benzamido hydroxamic acids have been synthesized and evaluated. This study has led to the discovery of novel inhibitors whose profiles include activity against TACE in an enzyme assay, potency in the suppression of LPS-stimulated TNF-alpha in human whole blood, selectivity against a panel of MMPs and oral bioavailability.
MeSH terms
-
ADAM Proteins / antagonists & inhibitors*
-
ADAM17 Protein
-
Administration, Oral
-
Animals
-
Biological Availability
-
Chromatography, High Pressure Liquid
-
Enzyme Inhibitors / chemical synthesis
-
Enzyme Inhibitors / chemistry*
-
Enzyme Inhibitors / pharmacology*
-
Humans
-
Hydroxamic Acids / administration & dosage
-
Hydroxamic Acids / chemical synthesis
-
Hydroxamic Acids / chemistry*
-
Hydroxamic Acids / pharmacokinetics
-
Hydroxamic Acids / pharmacology*
-
Rats
-
Stereoisomerism
Substances
-
Enzyme Inhibitors
-
Hydroxamic Acids
-
ADAM Proteins
-
ADAM17 Protein
-
ADAM17 protein, human
-
Adam17 protein, rat